Silas Martin | Head, Access & Policy Research
Johnson & Johnson

Silas Martin is the Head of Access and Policy Research at Johnson & Johnson Innovative Medicine, where he leads a team of researchers focused on generating novel evidence and fostering partnerships in support of policies that enable patient access to transformational innovation.  In his tenure at J&J, Silas has led teams, and published research is the areas of health economics, outcomes research, market access and healthcare policy. He is actively pursuing research to examine the patient impact of the FDA Accelerated Approval program across the diverse array of disease areas. Throughout his career, Silas has been a strong advocate for patients with rare diseases, working to break down barriers to access and improve outcomes for this underserved population. He has a proven track record of developing innovative strategies to navigate complex healthcare systems and drive policy changes that benefit patients. Silas is known for his collaborative approach, working closely with stakeholders across the healthcare ecosystem to find solutions that address the unique challenges faced by individuals with rare diseases.